When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 16 Hits
  • Search Condition : Filter (MeSH = Ovarian Neoplasms / drug therapy*)
Species Resource
Human and Animal Cells JHOC-7(RCB1688) Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma.
Human and Animal Cells JHOC-9(RCB2226) Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma.
Human and Animal Cells JHOC-5(RCB1520) Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma.
Human and Animal Cells JHOS-2(RCB1521) , JHOS-3(RCB1546) , JHOS-4(RCB1678) Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas.
Human and Animal Cells JHUEM-2(RCB1551) Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers.
Human and Animal Cells JHOC-5(RCB1520) ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors.
Human and Animal Cells JHOS-2(RCB1521) A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer.
Human and Animal Cells JHOC-5(RCB1520) Targeting glutamine metabolism and the focal adhesion kinase additively inhibits the mammalian target of the rapamycin pathway in spheroid cancer stem-like properties of ovarian clear cell carcinoma in vitro.
Human and Animal Cells Eribulin mesylate targets human telomerase reverse transcriptase in ovarian cancer cells.
Human and Animal Cells Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells.
Human and Animal Cells Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.
Human and Animal Cells OV2944- HM-1(RCB1483) Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer.
Human and Animal Cells IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer.
Human and Animal Cells OV2944-HM-1(RCB1483) AG490, a Jak2 inhibitor, suppressed the progression of murine ovarian cancer.
Human and Animal Cells NIH:OVCAR-3 (RCB2135) Sawano (RCB1152) Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer.
Human and Animal Cells NIH:OVCAR-3 (RCB2135) Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer.